Costs and consequences associated with misdiagnosed lower extremity cellulitis QY Weng, AB Raff, JM Cohen, N Gunasekera, JP Okhovat, P Vedak, ... JAMA dermatology 153 (2), 141-146, 2017 | 210 | 2017 |
Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne M Plovanich, QY Weng, A Mostaghimi JAMA dermatology 151 (9), 941-944, 2015 | 190 | 2015 |
UV signaling pathways within the skin H Chen, QY Weng, DE Fisher Journal of Investigative Dermatology 134 (8), 2080-2085, 2014 | 186 | 2014 |
Assessment of patient factors, surgeons, and surgeon teams in immediate implant-based breast reconstruction outcomes L Gfrerer, D Mattos, M Mastroianni, QY Weng, JA Ricci, MP Heath, A Lin, ... Plastic and reconstructive surgery 135 (2), 245e-252e, 2015 | 102 | 2015 |
Topical treatment strategies to manipulate human skin pigmentation I Rachmin, SM Ostrowski, QY Weng, DE Fisher Advanced drug delivery reviews 153, 65-71, 2020 | 79 | 2020 |
A UV-independent topical small-molecule approach for melanin production in human skin N Mujahid, Y Liang, R Murakami, HG Choi, AS Dobry, J Wang, Y Suita, ... Cell reports 19 (11), 2177-2184, 2017 | 79 | 2017 |
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses JA Lo, M Kawakubo, VR Juneja, MY Su, TH Erlich, MW LaFleur, ... Science translational medicine 13 (581), eabd8636, 2021 | 78 | 2021 |
A predictive model for diagnosis of lower extremity cellulitis: a cross-sectional study AB Raff, QY Weng, JM Cohen, N Gunasekera, JP Okhovat, P Vedak, ... Journal of the American Academy of Dermatology 76 (4), 618-625. e2, 2017 | 69 | 2017 |
Gain-of-function genetic alterations of G9a drive oncogenesis S Kato, QY Weng, ML Insco, KY Chen, S Muralidhar, J Pozniak, JMS Diaz, ... Cancer discovery 10 (7), 980-997, 2020 | 57 | 2020 |
NNT mediates redox-dependent pigmentation via a UVB-and MITF-independent mechanism J Allouche, I Rachmin, K Adhikari, LM Pardo, JH Lee, AM McConnell, ... Cell 184 (16), 4268-4283. e20, 2021 | 55 | 2021 |
Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells RE Tay, O Olawoyin, P Cejas, Y Xie, CA Meyer, Y Ito, QY Weng, ... Journal of Experimental Medicine 217 (7), e20191453, 2020 | 49 | 2020 |
Distance of travel to phototherapy is associated with early nonadherence: a retrospective cohort study QY Weng, E Buzney, C Joyce, A Mostaghimi Journal of the American Academy of Dermatology 74 (6), 1256-1259, 2016 | 13 | 2016 |
The ALT-70 cellulitis model maintains predictive value at 24 and 48 hours after presentation S Singer, DG Li, N Gunasekera, JP Okhovat, P Vedak, C Weng, J Cohen, ... Journal of the American Academy of Dermatology 81 (6), 1252-1256, 2019 | 12 | 2019 |
Gain-of-function genetic alterations of G9a drive oncogenesis. Cancer Discov. 2020; 10: 980–997. doi: 10.1158/2159-8290 S Kato, QY Weng, ML Insco, KY Chen, S Muralidhar, J Pozniak, JMS Diaz, ... CD-19-0532.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 9 | |
A 48-year-old male with cutaneous metastases of NUT midline carcinoma misdiagnosed as herpes zoster LN Ko, QY Weng, JS Song, M Asel, SR Granter, A Mostaghimi Case Reports in Oncology 10 (3), 987-991, 2018 | 6 | 2018 |
Costs and consequences associated with misdiagnosed lower extremity cellulitis [published online November 2, 2016] QY Weng, AB Raff, JM Cohen JAMA Dermatol 10, 0 | 6 | |
Costs and consequences associated with misdiagnosed lower extremity cellulitis. JAMA Dermatol. 2017; 153 (2): 141-146 QY Weng, AB Raff, JM Cohen | 5 | 2016 |
Costs and consequences associated with misdiagnosed lower extremity cellulitis. JAMA Dermatol. 2017; 153 (2): 141–6 QY Weng, AB Raff, JM Cohen, N Gunasekera, JP Okhovat, P Vedak, ... Epub 2016/11/03. doi: 10.1001/jamadermatol. 2016.3816. PubMed PMID: 27806170, 0 | 5 | |
Use of health care resources and costs after patient nonattendance in dermatology K Halim, QY Weng, I Kuye, C Joyce, A Mostaghimi JAMA dermatology 152 (2), 220-221, 2016 | 4 | 2016 |
Treatment of cancers having alterations within the SWI/SNF chromatin remodeling complex DE Fisher, QY Weng, S Kato US Patent 11,433,068, 2022 | 1 | 2022 |